VICTORY CAPITAL MANAGEMENT INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2023$7,293
+22.7%
10,166
-0.9%
0.00%
Q4 2022$5,945
-40.6%
10,259
-0.0%
0.00%
Q3 2022$10,000
-23.1%
10,262
-4.0%
0.00%
Q2 2022$13,000
+8.3%
10,685
-6.1%
0.00%
Q1 2022$12,000
-42.9%
11,384
-2.8%
0.00%
Q4 2021$21,000
-19.2%
11,709
-1.8%
0.00%
Q3 2021$26,000
-40.9%
11,922
-4.6%
0.00%
Q2 2021$44,000
-95.9%
12,500
-88.4%
0.00%
-100.0%
Q1 2021$1,064,000
-12.6%
107,938
-4.0%
0.00%0.0%
Q4 2020$1,218,000
-8.5%
112,387
-13.0%
0.00%
-50.0%
Q3 2020$1,331,000
-51.3%
129,171
-1.3%
0.00%
-50.0%
Q2 2020$2,733,000
-82.4%
130,870
-91.7%
0.00%
-69.2%
Q1 2020$15,492,000
+63.8%
1,585,644
+93.2%
0.01%
+18.2%
Q4 2019$9,457,000
+204.1%
820,877
+43.9%
0.01%
+175.0%
Q3 2019$3,110,000
+34.2%
570,595
+192.8%
0.00%
-20.0%
Q2 2019$2,317,000
+113.5%
194,900
-5.8%
0.01%
+150.0%
Q1 2019$1,085,000
+64.6%
207,010
-1.1%
0.00%0.0%
Q4 2018$659,000
-25.8%
209,340
+42.7%
0.00%0.0%
Q3 2018$888,000
+8.3%
146,700
-5.2%
0.00%0.0%
Q2 2018$820,000
-13.6%
154,740
-5.4%
0.00%0.0%
Q1 2018$949,000163,5800.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders